{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:12:05Z","timestamp":1791223925869,"version":"4.1.0"},"reference-count":94,"publisher":"American Psychiatric Association Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2004,4,1]]},"DOI":"10.1176\/appi.ajp.161.4.608","type":"journal-article","created":{"date-parts":[[2004,3,31]],"date-time":"2004-03-31T17:42:58Z","timestamp":1080754978000},"page":"608-620","source":"Crossref","is-referenced-by-count":313,"title":["Management of Bipolar Disorder During Pregnancy and the Postpartum Period"],"prefix":"10.1176","volume":"161","author":[{"given":"Kimberly A.","family":"Yonkers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Wisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Leibenluft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Manber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Viguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Suppes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Altshuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1614CHDJFDEG","doi-asserted-by":"crossref","unstructured":"Leibenluft E: Women with bipolar illness: clinical and research issues. Am J Psychiatry 1996; 153:163\u2013173","DOI":"10.1176\/ajp.153.2.163"},{"key":"R1614CHDJEAHI","doi-asserted-by":"crossref","unstructured":"Grof P: Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord 2000; 61:31\u201339","DOI":"10.1016\/S0165-0327(99)00197-4"},{"key":"R1614CHDEBIED","doi-asserted-by":"crossref","unstructured":"Kendell RE, Chalmers JC, Platz C: Epidemiology of puerperal psychoses. Br J Psychiatry 1987; 150:662\u2013673","DOI":"10.1192\/bjp.150.5.662"},{"key":"R1614CHDGCCDA","doi-asserted-by":"crossref","unstructured":"Pugh TF, Jerath BK, Schmidt WM, Reed RB: Rates of mental disease related to childbearing. N Engl J Med 1963; 268:1224\u20131228","DOI":"10.1056\/NEJM196305302682205"},{"key":"R1614CHDCHDDE","doi-asserted-by":"crossref","unstructured":"Terp IM, Mortensen PB: Postpartum psychoses: clinical diagnoses and relative risk of admission after parturition. Br J Psychiatry 1998; 172:521\u2013526","DOI":"10.1192\/bjp.172.6.521"},{"key":"R1614CHDDDBIE","doi-asserted-by":"crossref","unstructured":"Freeman M, Smith K, Freeman S, McElroy S, Kmetz G, Wright R, Keck P: The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry 2002; 63:284\u2013287","DOI":"10.4088\/JCP.v63n0403"},{"key":"R1614CHDCHFAJ","doi-asserted-by":"crossref","unstructured":"Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ: Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000; 157:179\u2013184","DOI":"10.1176\/appi.ajp.157.2.179"},{"key":"R1614CHDCAHCH","doi-asserted-by":"crossref","unstructured":"Wisner KL, Zarin D, Holmboe E, Appelbaum P, Gelenberg AJ, Leonard HL, Frank E: Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry 2000; 157:1933\u20131940","DOI":"10.1176\/appi.ajp.157.12.1933"},{"key":"R1614CHDJHBBA","doi-asserted-by":"crossref","unstructured":"Moncrieff J: Lithium revisited: a re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder. Br J Psychiatry 1995; 167:569\u2013574","DOI":"10.1192\/bjp.167.5.569"},{"key":"R1614CHDICDHB","doi-asserted-by":"crossref","unstructured":"Schou M, Goldfield MD, Weinstein MR, Villeneuve A: Lithium and pregnancy, I: report from the Register of Lithium Babies. Br Med J 1973; 2:135\u2013136","DOI":"10.1136\/bmj.2.5859.135"},{"key":"R1614CHDIFJAG","doi-asserted-by":"crossref","unstructured":"Nora JJ, Nora AH, Toews WH: Lithium, Ebstein\u2019s anomaly, and other congenital heart defects (letter). Lancet 1974; 2:594\u2013595","DOI":"10.1016\/S0140-6736(74)91918-7"},{"key":"R1614CHDBAIJJ","unstructured":"Edmonds LD, Oakley GP: Ebstein\u2019s anomaly and maternal lithium exposure during pregnancy. Teratology 1990; 41:551\u2013552"},{"key":"R1614CHDHIGJD","doi-asserted-by":"crossref","unstructured":"Jacobson SJ, Jones K, Johnson K, Ceolin L, Kauer P, Sahn K, Konnenfeld AE, Rieder M, Santelli R, Smythe J, Pastuszak A, Einarson T, Koren G: Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992; 339:530\u2013533","DOI":"10.1016\/0140-6736(92)90346-5"},{"key":"R1614CHDJBBIH","doi-asserted-by":"crossref","unstructured":"Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML: A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271:146\u2013150","DOI":"10.1001\/jama.271.2.146"},{"key":"R1614CHDJGCHF","doi-asserted-by":"crossref","unstructured":"Schou M: What happened later to the lithium babies? a follow-up study of children born without malformations. Acta Psychiatr Scand 1976; 54:193\u2013197","DOI":"10.1111\/j.1600-0447.1976.tb00112.x"},{"key":"R1614CHDHICJI","doi-asserted-by":"crossref","unstructured":"Ananth J: Side effects in the neonate from psychotropic agents excreted through breast-feeding. Am J Psychiatry 1978; 135:801\u2013805","DOI":"10.1176\/ajp.135.7.801"},{"key":"R1614CHDEBHBC","doi-asserted-by":"crossref","unstructured":"Schou M, Amdisen A: Lithium and pregnancy, 3: lithium ingestion by children breast-fed by women on lithium treatment. Br Med J 1973; 2:138","DOI":"10.1136\/bmj.2.5859.138"},{"key":"R1614CHDGAJDG","doi-asserted-by":"crossref","unstructured":"Mizrahi EM, Hobbs JF, Goldsmith DI: Nephrogenic diabetes insipidus in transplacental lithium intoxication. J Pediatr 1979; 94:493\u2013495","DOI":"10.1016\/S0022-3476(79)80610-1"},{"key":"R1614CHDIACIH","doi-asserted-by":"crossref","unstructured":"Nars PW, Girard J: Lithium carbonate intake during pregnancy leading to large goiter in a premature infant. Am J Dis Child 1977; 131:924\u2013925","DOI":"10.1001\/archpedi.1977.02120210102021"},{"key":"R1614CHDBEDFJ","doi-asserted-by":"crossref","unstructured":"Goldfield MD, Weinstein MR: Lithium carbonate in obstetrics: guidelines for clinical use. Am J Obstet Gynecol 1973; 116:15\u201322","DOI":"10.1016\/0002-9378(73)90876-4"},{"key":"R1614CHDCAHCC","doi-asserted-by":"crossref","unstructured":"Schou M, Amdisen A, Steenstrup OR: Lithium and pregnancy, II: hazards to women given lithium during pregnancy and delivery. Br Med J 1973; 2:137\u2013138","DOI":"10.1136\/bmj.2.5859.137"},{"key":"R1614CHDDHAIC","doi-asserted-by":"crossref","unstructured":"MacKay AVP, Loose R, Glen AIM: Labour on lithium. Br Med J 1976; 1:878","DOI":"10.1136\/bmj.1.6014.878"},{"key":"R1614CHDDBEAD","doi-asserted-by":"crossref","unstructured":"Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J: Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996; 153:592\u2013606","DOI":"10.1176\/ajp.153.5.592"},{"key":"R1614CHDDFJCG","doi-asserted-by":"crossref","unstructured":"Crawford P, Appleton R, Betts T, Duncan J, Guthrie E, Morrow J: Best practice guidelines for the management of women with epilepsy. Seizure 1999; 8:201\u2013217","DOI":"10.1053\/seiz.1999.0295"},{"key":"R1614CHDFGIHD","doi-asserted-by":"crossref","unstructured":"Jones KL, Lacro RV, Johnson KA, Adams J: Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989; 320:1661\u20131666","DOI":"10.1056\/NEJM198906223202505"},{"key":"R1614CHDDDEFE","unstructured":"Delgado-Escueta A, Janz D: Consensus guidelines: preconception counseling, management, and care of pregnant women with epilepsy. Neurology 1992; 42:149\u2013160"},{"key":"R1614CHDHDBDI","doi-asserted-by":"crossref","unstructured":"Nakane Y, Okuma T, Takahashi R: Multi-institutional study on teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 1980; 21:663\u2013680","DOI":"10.1111\/j.1528-1157.1980.tb04320.x"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Omtzigt J: Prenatal diagnosis of spina bifida aperta after first-trimester valproate exposure. Prenat Diagn 1992; 12:893\u2013897","DOI":"10.1002\/pd.1970121107"},{"key":"R1614CHDDAACB","unstructured":"Kennedy D, Koren G: Valproic acid use in psychiatry: issues in treating women of reproductive age. J Psychiatry Neurosci 1998; 23:223\u2013228"},{"key":"R1614CHDIFCAG","doi-asserted-by":"crossref","unstructured":"Omtzigt J: The disposition of valproate and its metabolites in the late first trimester and early second trimester of pregnancy in maternal serum, urine, and amniotic fluid: effect of dose, co-medication, and the presence of spina bifida. Eur J Clin Pharmacol 1992; 43:381\u2013388","DOI":"10.1007\/BF02220613"},{"key":"R1614CHDIJIBD","doi-asserted-by":"crossref","unstructured":"Jager-Roman E: Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986; 108:997\u20131004","DOI":"10.1016\/S0022-3476(86)80949-0"},{"key":"R1614CHDDHIJI","doi-asserted-by":"crossref","unstructured":"DiLiberti J, Farndon P, Dennis N, Curry C: The fetal valproate syndrome. Am J Med Genet 1984; 19:473\u2013481","DOI":"10.1002\/ajmg.1320190308"},{"key":"R1614CHDFDJEJ","doi-asserted-by":"crossref","unstructured":"Felding I, Rane A: Congenital liver damage after treatment of mother with valproic acid and phenytoin. Acta Paediatr Scand 1984; 73:565\u2013568","DOI":"10.1111\/j.1651-2227.1984.tb09974.x"},{"key":"R1614CHDIJFCF","doi-asserted-by":"crossref","unstructured":"Thisted E, Ebbesen F: Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. Arch Dis Child 1993; 69:288\u2013291","DOI":"10.1136\/adc.69.3_Spec_No.288"},{"key":"R1614CHDDHBDF","doi-asserted-by":"crossref","unstructured":"Majer R, Green P: Neonatal afibrinogenaemia due to sodium valproate. Lancet 1987; 2:740\u2013741","DOI":"10.1016\/S0140-6736(87)91098-1"},{"key":"R1614CHDDJDEF","doi-asserted-by":"crossref","unstructured":"American Academy of Neurology: Practice parameter: management issues for women with epilepsy (summary statement): report of the Quality Standard Subcommittee of the American Academy of Neurology. Neurology 1998; 51:944\u2013948","DOI":"10.1212\/WNL.51.4.944"},{"key":"R1614CHDDCDGG","unstructured":"Nau H, Rating D, Koch S, Hauser I, Helge H: Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother\u2019s milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther 1981; 219:768\u2013777"},{"key":"R1614CHDCGBGB","doi-asserted-by":"crossref","unstructured":"Crawford P, Appleton R, Betts T, Duncan J, Guthrie E, Morrow J (Women With Epilepsy Guidelines Development Group): Best practice guidelines for the management of women with epilepsy. Seizure 1999; 8:201\u2013217","DOI":"10.1053\/seiz.1999.0295"},{"key":"R1614AAAAA","doi-asserted-by":"crossref","unstructured":"Rosa FW: Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991; 324:674\u2013677","DOI":"10.1056\/NEJM199103073241006"},{"key":"R1614CHDJDCFH","unstructured":"Lindhout D: Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology 1992; 42:94\u2013110"},{"key":"R1614CHDCHDJA","doi-asserted-by":"crossref","unstructured":"Diav-Citrin O, Shechtman S, Arnon J, Ornoy A: Is carbamazepine teratogenic? a prospective controlled study of 210 pregnancies. Neurology 2001; 57:321\u2013324","DOI":"10.1212\/WNL.57.2.321"},{"key":"R1614CHDHGHIJ","doi-asserted-by":"crossref","unstructured":"Hiilesmaa VK, Teramo K, Granstrom ML, Bardy AH: Fetal head growth retardation associated with maternal antiepileptic drugs. Lancet 1981; 2:165\u2013167","DOI":"10.1016\/S0140-6736(81)90354-8"},{"key":"R1614CHDJBBEI","doi-asserted-by":"crossref","unstructured":"Scolnick D: Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 1994; 271:767\u2013770","DOI":"10.1001\/jama.271.10.767"},{"key":"R1614CHDEDCGG","doi-asserted-by":"crossref","unstructured":"Frey B, Schubiger G, Musy J: Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breastfeeding. Eur J Pediatr 1990; 150:136\u2013138","DOI":"10.1007\/BF02072057"},{"key":"R1614CHDJCBDC","doi-asserted-by":"crossref","unstructured":"Merlob P, Mor N, Litwin A: Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding. Ann Pharmacother 1992; 26:1563\u20131565","DOI":"10.1177\/106002809202601215"},{"key":"R1614CHDDBFHD","doi-asserted-by":"crossref","unstructured":"Nau H, Kuhnz W, Egger H, Rating D, Hedge H: Anticonvulsants during pregnancy and lactation: transplacental, maternal and neonatal pharmacokinetics. Clin Pharmacokinet 1982; 6:508\u2013543","DOI":"10.2165\/00003088-198207060-00003"},{"key":"R1614CHDBEIFI","doi-asserted-by":"crossref","unstructured":"Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R: Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Lancet 1999; 353:2190\u20132194","DOI":"10.1016\/S0140-6736(98)05418-X"},{"key":"R1614CHDDBEFC","doi-asserted-by":"crossref","unstructured":"Calabrese J, Suppes T, Bowden C, Sachs G, Swann A, McElroy S, Kusumakar V, Ascher J, Earl N, Greene P, Monaghan E: A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000; 61:841\u2013850","DOI":"10.4088\/JCP.v61n1106"},{"key":"R1614CHDBCCJC","doi-asserted-by":"crossref","unstructured":"Mackay F, O\u2019Brien T, Hitchcock A: Safety of long-term lamotrigine in epilepsy. Epilepsia 1997; 38:881\u2013886","DOI":"10.1111\/j.1528-1157.1997.tb01252.x"},{"key":"R1614CHDJJGDJ","doi-asserted-by":"crossref","unstructured":"Ohman I, Vitols S, Tomson T: Lamotrigine in pregnancy, pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000; 41:709\u2013713","DOI":"10.1111\/j.1528-1157.2000.tb00232.x"},{"key":"R1614CHDCIEIC","doi-asserted-by":"crossref","unstructured":"Tran TA, Leppik IE, Blesi K, Sathanandan ST, Remmel R: Lamotrigine clearance during pregnancy. Neurology 2002; 59:251\u2013255","DOI":"10.1212\/WNL.59.2.251"},{"key":"R1614CHDCICID","doi-asserted-by":"crossref","unstructured":"Pande A: Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 2000; 20:467\u2013471","DOI":"10.1097\/00004714-200008000-00011"},{"key":"R1614CHDFBDEB","doi-asserted-by":"crossref","unstructured":"Frye M: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20:607\u2013617","DOI":"10.1097\/00004714-200012000-00004"},{"key":"R1614CHDCADFJ","doi-asserted-by":"crossref","unstructured":"Rumeau-Rouquette C, Goujard J, Huel G: Possible teratogenic effect of phenothiazines in human beings. Teratology 1976; 15:57\u201364","DOI":"10.1002\/tera.1420150108"},{"key":"R1614CHDDHGCB","doi-asserted-by":"crossref","unstructured":"Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S: Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol 1977; 128:486\u2013488","DOI":"10.1016\/0002-9378(77)90029-1"},{"key":"R1614CHDIHHDF","doi-asserted-by":"crossref","unstructured":"Sobel D: Fetal damage due to ECT, insulin coma, chlorpromazine or reserpine. Arch Gen Psychiatry 1960; 2:606\u2013611","DOI":"10.1001\/archpsyc.1960.03590120014002"},{"key":"R1614CHDCEFBJ","doi-asserted-by":"crossref","unstructured":"Van Waes A, Van de Velde E: Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum. J Clin Pharmacol 1969; 9:224\u2013227","DOI":"10.1177\/009127006900900403"},{"key":"R1614CHDDEEJG","unstructured":"Sexson WR, Barak Y: Withdrawal emergent syndrome in an infant associated with maternal haloperidol therapy. J Perinatol 1989; 9:170\u2013172"},{"key":"R1614CHDDDIAF","unstructured":"Ayd F: Is psychiatry in a crisis because of the complications of the psychopharmaceuticals? Dis Nerv Syst 1968; 29:23\u201325"},{"key":"R1614CHDJEDAE","doi-asserted-by":"crossref","unstructured":"Hammond J, Toseland P: Placental transfer of chlorpromazine. Arch Child Dis 1970; 45:139\u2013140","DOI":"10.1136\/adc.45.239.139"},{"key":"R1614CHDJJDEF","doi-asserted-by":"crossref","unstructured":"Edlund MJ, Craig TJ: Antipsychotic drug use and birth defects: an epidemiologic reassessment. Compr Psychiatry 1984; 25:32\u201337","DOI":"10.1016\/0010-440X(84)90019-1"},{"key":"R1614CHDFEABB","unstructured":"McElroy S, Keck P, Stanton S, Tugrul K, Bennett J, Strakowski S: A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996; 57:142\u2013146"},{"key":"R1614CHDIBBAF","doi-asserted-by":"crossref","unstructured":"Goldstein D: Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 2000; 20:399\u2013403","DOI":"10.1097\/00004714-200008000-00002"},{"key":"R1614CHDECGDH","doi-asserted-by":"crossref","unstructured":"Littrell KH, Johnson CG, Peabody CD, Hilligoss N: Antipsychotics during pregnancy (letter). Am J Psychiatry 2000; 157:1342","DOI":"10.1176\/appi.ajp.157.8.1342"},{"key":"R1614CHDBEECE","doi-asserted-by":"crossref","unstructured":"Dickson R: Olanzapine and pregnancy. Can J Psychiatry 1998; 43:196\u2013197","DOI":"10.1177\/070674379804300911"},{"key":"R1614CHDIDAFE","doi-asserted-by":"crossref","unstructured":"Kirchheiner J, Berghofer A, Bolk-Weischedel D: Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry 2000; 33:78\u201380","DOI":"10.1055\/s-2000-7974"},{"key":"R1614CHDJGDDD","doi-asserted-by":"crossref","unstructured":"Dose M, Emrich HM, Cording-Tommel C, von Zerssen D: Use of calcium antagonists in mania. Psychoneuroendocrinology 1986; 11:241\u2013243","DOI":"10.1016\/0306-4530(86)90060-0"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Dubovsky SL, Franks RD, Allen S, Murphy J: Calcium antagonists in mania: a double-blind study of verapamil. Psychiatry Res 1986; 18:309\u2013320","DOI":"10.1016\/0165-1781(86)90016-8"},{"key":"R1614CHDBACGI","doi-asserted-by":"crossref","unstructured":"Janicak PG, Sharma RP, Pandey G, Davis JM: Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial. Am J Psychiatry 1998; 155:972\u2013973","DOI":"10.1176\/ajp.155.7.972"},{"key":"R1614CHDCFCAJ","doi-asserted-by":"crossref","unstructured":"Wisner K, Peindl K, Perel J, Hanusa B, Piontek C, Baab S: Verapamil treatment for women with bipolar disorder. Biol Psychiatry 2002; 51:745\u2013752","DOI":"10.1016\/S0006-3223(01)01338-5"},{"key":"R1614CHDJFFJA","doi-asserted-by":"crossref","unstructured":"Magee L, Schick B, Donnenfeld A, Sage R, Conover B, Cook L, McElhatton P, Schmidt M, Koren G: The safety of calcium channel blockers in human pregnancy: a prospective multicenter study. Am J Obstet Gynecol 1996; 174:823\u2013828","DOI":"10.1016\/S0002-9378(96)70307-1"},{"key":"R1614CHDFAIBF","doi-asserted-by":"crossref","unstructured":"Marlettini M, Cassani A, Morselli-Labate A, Crippa S, Contarini A, Miniero R, Plate L, Orlandi C: Maternal and fetal prolactin in pregnancy-induced hypertension. Arch Gynecol Obstet 1990; 247:73\u201381","DOI":"10.1007\/BF02390664"},{"key":"R1614CHDCCADH","doi-asserted-by":"crossref","unstructured":"Aarskog D: Association between maternal intake of diazepam and oral clefts (letter). Lancet 1975; 2:921","DOI":"10.1016\/S0140-6736(75)92153-4"},{"key":"R1614CHDCFHCC","doi-asserted-by":"crossref","unstructured":"McElhatton PR: The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994; 8:461\u2013475","DOI":"10.1016\/0890-6238(94)90029-9"},{"key":"R1614CHDDGAAD","doi-asserted-by":"crossref","unstructured":"Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR: Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. Br Med J Clin Res Ed 1998; 317:839\u2013843","DOI":"10.1136\/bmj.317.7162.839"},{"key":"R1614CHDCBGAG","doi-asserted-by":"crossref","unstructured":"Davenport YB, Adland ML: Postpartum psychoses in female and male bipolar manic-depressive patients. Am J Orthopsychiatry 1982; 52:288\u2013297","DOI":"10.1111\/j.1939-0025.1982.tb02689.x"},{"key":"R1614CHDFEIII","doi-asserted-by":"crossref","unstructured":"Laegreid L, Olegard R, Wahlstrom J, Conradi N: Abnormalities in children exposed to benzodiazepines in utero (letter). Lancet 1987; 1:108\u2013109","DOI":"10.1016\/S0140-6736(87)91951-9"},{"key":"R1614CHDJDFBI","doi-asserted-by":"crossref","unstructured":"Weinstock L: Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series. Psychother Psychosom 1996; 70:158\u2013162","DOI":"10.1159\/000056242"},{"key":"R1614CHDFBHBF","doi-asserted-by":"crossref","unstructured":"Laegreid L, Hagberg G, Lundberg A: Neurodevelopment in late infancy after prenatal exposure to benzodiazepines\u2014a prospective study. Neuropediatrics 1992; 23:60\u201367","DOI":"10.1055\/s-2008-1071314"},{"key":"R1614CHDCHHJA","doi-asserted-by":"crossref","unstructured":"Bergman U, Rosa FW, Baum C, Wiholm BE, Faich GA: Effects of exposure to benzodiazepine during fetal life. Lancet 1992; 340:694\u2013696","DOI":"10.1016\/0140-6736(92)92232-5"},{"key":"R1614CHDEGAIB","unstructured":"Impastato D, Gabriel A, Lardaro H: Electric and insulin shock therapy during pregnancy. Dis Nerv Syst 1964; 25:542\u2013546"},{"key":"R1614CHDIEHCE","doi-asserted-by":"crossref","unstructured":"Miller LJ: Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 1994; 45:444\u2013450","DOI":"10.1176\/ps.45.5.444"},{"key":"R1614CHDJICGA","doi-asserted-by":"crossref","unstructured":"Polster D, Wisner K: ECT-induced premature labor: a case report. J Clin Psychiatry 1999; 60:53\u201354","DOI":"10.4088\/JCP.v60n0112a"},{"key":"R1614CHDIJCIE","doi-asserted-by":"crossref","unstructured":"Ehlers CL, Frank E, Kupfer DJ: Social zeitgebers and biological rhythms: a unified approach to understanding the etiology of depression. Arch Gen Psychiatry 1988; 45:948\u2013952","DOI":"10.1001\/archpsyc.1988.01800340076012"},{"key":"R1614CHDDJFIA","doi-asserted-by":"crossref","unstructured":"Suppes T, Baldessarini RJ, Faedda GL, Tohen M: Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991; 48:1082\u20131088","DOI":"10.1001\/archpsyc.1991.01810360046007"},{"key":"R1614CHDFFAFI","doi-asserted-by":"crossref","unstructured":"Laegreid L, Kyllerman M, Hedner T, Hagberg B, Viggedahl G: Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy. Neuropediatrics 1993; 24:88\u201392","DOI":"10.1055\/s-2008-1071520"},{"key":"R1614CHDFAHAF","doi-asserted-by":"crossref","unstructured":"Stewart DE, Klompenhouwer JL, Kendell RE, van Hulst AM: Prophylactic lithium in puerperal psychosis: the experience of three centers. Br J Psychiatry 1991; 158:393\u2013397","DOI":"10.1192\/bjp.158.3.393"},{"key":"R1614CHDEDAFJ","doi-asserted-by":"crossref","unstructured":"Cohen LS, Sichel DA, Robertson LM, Heckscher E, Rosenbaum JF: Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry 1995; 152:1641\u20131645","DOI":"10.1176\/ajp.152.11.1641"},{"key":"R1614CHDIGFCJ","doi-asserted-by":"crossref","unstructured":"Gartner L: Breastfeeding and the use of human milk. Pediatrics 1997; 100:1035\u20131039","DOI":"10.1542\/peds.100.6.1035"},{"key":"R1614CHDGCHJD","doi-asserted-by":"crossref","unstructured":"von Unruh G, Froescher W, Hoffmann F, Niesen M: Valproic acid in breast milk: how much is really there? Ther Drug Monit 1984; 6:272\u2013276","DOI":"10.1097\/00007691-198409000-00003"},{"key":"R1614CHDJDBFG","doi-asserted-by":"crossref","unstructured":"Wisner K, Perel J: Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. Psychopharmacology (Berl) 1998; 18:167\u2013169","DOI":"10.1097\/00004714-199804000-00009"},{"key":"R1614CHDCGAGJ","doi-asserted-by":"crossref","unstructured":"Holmes L, Harvey E, Coull B, Huntington K, Khoshbin S, Ailish M, Ryan L: The teratogenicity of anticonvulsant drugs. N Engl J Med 2001; 344:1132\u20131138","DOI":"10.1056\/NEJM200104123441504"},{"key":"R1614CHDFIJII","doi-asserted-by":"crossref","unstructured":"Chaudron L: Mood stabilizers during breastfeeding: a review. J Clin Psychiatry 2000; 61:79\u201390","DOI":"10.4088\/JCP.v61n0202"},{"key":"R1614CHDCHFDB","doi-asserted-by":"crossref","unstructured":"Patrick M, Tilstone W, Reavey P: Diazepam and breastfeeding. Lancet 1972; 1:542\u2013543","DOI":"10.1016\/S0140-6736(72)90216-4"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.161.4.608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T08:05:52Z","timestamp":1722153952000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.161.4.608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4,1]]}},"alternative-id":["10.1176\/appi.ajp.161.4.608"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.161.4.608","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,1]]}}}